ReviewCancer reports (Hoboken, N.J.)2019

Mass spectrometry imaging to detect lipid biomarkers and disease signatures in cancer.

Matthias Holzlechner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.